{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:00:10Z","timestamp":1781668810162,"version":"3.54.5"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T00:00:00Z","timestamp":1395705600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1038\/nrgastro.2014.32","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T11:10:13Z","timestamp":1395745813000},"page":"426-434","source":"Crossref","is-referenced-by-count":96,"title":["Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy"],"prefix":"10.1038","volume":"11","author":[{"given":"Julian R. F.","family":"Walters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,25]]},"reference":[{"key":"BFnrgastro201432_CR1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0016-5085(67)80140-9","volume":"52","author":"AF Hofmann","year":"1967","unstructured":"Hofmann, A. F. The syndrome of ileal disease and the broken enterohepatic circulation: cholerheic enteropathy. Gastroenterology 52, 752\u2013757 (1967).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201432_CR2","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/bjs.1800811122","volume":"81","author":"J Cosnes","year":"1994","unstructured":"Cosnes, J. et al. Classification of the sequelae of bowel resection for Crohn's disease. Br. J. Surg. 81, 1627\u20131631 (1994).","journal-title":"Br. J. Surg."},{"key":"BFnrgastro201432_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/gut.53.1.78","volume":"53","author":"D Jung","year":"2004","unstructured":"Jung, D., Fantin, A. C., Scheurer, U., Fried, M. & Kullak-Ublick, G. A. Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor. Gut 53, 78\u201384 (2004).","journal-title":"Gut"},{"key":"BFnrgastro201432_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1056\/NEJM196908212810801","volume":"281","author":"AF Hofmann","year":"1969","unstructured":"Hofmann, A. F. & Poley, J. R. Cholestyramine treatment of diarrhea associated with ileal resection. N. Engl. J. Med. 281, 397\u2013402 (1969).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201432_CR5","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1136\/gut.17.12.965","volume":"17","author":"EH Thaysen","year":"1976","unstructured":"Thaysen, E. H. & Pedersen, L. Idiopathic bile acid catharsis. Gut 17, 965\u2013970 (1976).","journal-title":"Gut"},{"issue":"Suppl. 5","key":"BFnrgastro201432_CR6","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1136\/gut.52.suppl_5.v1","volume":"52","author":"PD Thomas","year":"2003","unstructured":"Thomas, P. D. et al. Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut 52 (Suppl. 5), v1\u2013v15 (2003).","journal-title":"Gut"},{"key":"BFnrgastro201432_CR7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/ajg.2010.69","volume":"105","author":"RC Spiller","year":"2010","unstructured":"Spiller, R. C. & Thompson, W. G. Bowel disorders. Am. J. Gastroenterol. 105, 775\u2013785 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201432_CR8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0300-5089(21)00739-2","volume":"15","author":"H Fromm","year":"1986","unstructured":"Fromm, H. & Malavolti, M. Bile acid-induced diarrhoea. Clin. Gastroenterol. 15, 567\u2013582 (1986).","journal-title":"Clin. Gastroenterol."},{"key":"BFnrgastro201432_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/gut.32.5.500","volume":"32","author":"AJ van Tilburg","year":"1991","unstructured":"van Tilburg, A. J., de Rooij, F. W., van den Berg, J. W. & van Blankenstein, M. Primary bile acid diarrhoea without an ileal carrier defect: quantification of active bile acid transport across the ileal brush border membrane. Gut 32, 500\u2013503 (1991).","journal-title":"Gut"},{"key":"BFnrgastro201432_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3109\/00365529209096030","volume":"194","author":"AJ van Tilburg","year":"1992","unstructured":"van Tilburg, A. J., de Rooij, F. W., van den Berg, J. W. & van Blankenstein, M. Primary bile acid malabsorption: a pathophysiologic and clinical entity? Scand. J. Gastroenterol. Suppl. 194, 66\u201370 (1992).","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"BFnrgastro201432_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/00042737-200604000-00013","volume":"18","author":"A Bajor","year":"2006","unstructured":"Bajor, A. et al. Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. Eur. J. Gastroenterol. Hepatol. 18, 397\u2013403 (2006).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201432_CR12","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1101\/gad.1083503","volume":"17","author":"JA Holt","year":"2003","unstructured":"Holt, J. A. et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 17, 1581\u20131591 (2003).","journal-title":"Genes Dev."},{"key":"BFnrgastro201432_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","volume":"2","author":"T Inagaki","year":"2005","unstructured":"Inagaki, T. et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell. Metab. 2, 217\u2013225 (2005).","journal-title":"Cell. Metab."},{"key":"BFnrgastro201432_CR14","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cgh.2009.04.024","volume":"7","author":"JRF Walters","year":"2009","unstructured":"Walters, J. R. F. et al. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin. Gastroenterol. Hepatol. 7, 1189\u20131194 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201432_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1586\/egh.09.49","volume":"3","author":"AF Hofmann","year":"2009","unstructured":"Hofmann, A. F. Chronic diarrhea caused by idiopathic bile acid malabsorption: an explanation at last. Expert Rev. Gastroenterol. Hepatol. 3, 461\u2013464 (2009).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro201432_CR16","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1586\/egh.10.54","volume":"4","author":"JR Walters","year":"2010","unstructured":"Walters, J. R. Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder. Expert Rev. Gastroenterol. Hepatol. 4, 561\u2013567 (2010).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro201432_CR17","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/j.1365-2982.2012.01953.x","volume":"24","author":"DJ Gracie","year":"2012","unstructured":"Gracie, D. J. et al. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol. Motil. 24, 983\u2013e538 (2012).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro201432_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.7861\/clinmedicine.10-2-124","volume":"10","author":"U Khalid","year":"2010","unstructured":"Khalid, U., Lalji, A., Stafferton, R. & Andreyev, J. Bile acid malabsorption: a forgotten diagnosis? Clin. Medicine 10, 124\u2013126 (2010).","journal-title":"Clin. Medicine"},{"key":"BFnrgastro201432_CR19","unstructured":"Waters, J. For 40 years, doctors said I had IBS. In fact it was a hormone problem cured by a simple pill. Daily Mail (1 Jan 2013)."},{"key":"BFnrgastro201432_CR20","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.cgh.2013.04.029","volume":"11","author":"P Vijayvargiya","year":"2013","unstructured":"Vijayvargiya, P., Camilleri, M., Shin, A. & Saenger, A. Methods for diagnosis of bile acid malabsorption in clinical practice. Clin. Gastroenterol. Hepatol. 11, 1232\u20131239 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201432_CR21","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1136\/gut.23.10.862","volume":"23","author":"EH Thaysen","year":"1982","unstructured":"Thaysen, E. H., Orholm, M., Arnfred, T., Carl, J. & Rodbro, P. Assessment of ileal function by abdominal counting of the retention of a \u03b3 emitting bile acid analogue. Gut 23, 862\u2013865 (1982).","journal-title":"Gut"},{"key":"BFnrgastro201432_CR22","first-page":"720","volume":"22","author":"GS Boyd","year":"1981","unstructured":"Boyd, G. S., Merrick, M. V., Monks, R. & Thomas, I. L. Se-75-labeled bile acid analogs, new radiopharmaceuticals for investigating the enterohepatic circulation. J. Nucl. Med. 22, 720\u2013725 (1981).","journal-title":"J. Nucl. Med."},{"key":"BFnrgastro201432_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/bmj.290.6469.665","volume":"290","author":"MV Merrick","year":"1985","unstructured":"Merrick, M. V., Eastwood, M. A. & Ford, M. J. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. Br. Med. J. (Clin. Res. Ed.) 290, 665\u2013668 (1985).","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"BFnrgastro201432_CR24","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/gut.28.8.970","volume":"28","author":"G Sciarretta","year":"1987","unstructured":"Sciarretta, G. et al. 75SeHCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit. Gut 28, 970\u2013975 (1987).","journal-title":"Gut"},{"key":"BFnrgastro201432_CR25","doi-asserted-by":"crossref","unstructured":"Hofmann, A. F. Enterohepatic circulation of bile acids. Compr. Physiol. 567\u2013596 (2011).","DOI":"10.1002\/cphy.cp060329"},{"key":"BFnrgastro201432_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/1756283X10377126","volume":"3","author":"JRF Walters","year":"2010","unstructured":"Walters, J. R. F. & Pattni, S. S. Managing bile acid diarrhoea. Ther. Adv. Gastroenterol. 3, 349\u2013357 (2010).","journal-title":"Ther. Adv. Gastroenterol."},{"key":"BFnrgastro201432_CR27","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1007\/s00259-013-2466-z","volume":"40","author":"AM Peters","year":"2013","unstructured":"Peters, A. M. & Walters, J. R. Recycling rate of bile acids in the enterohepatic recirculation as a major determinant of whole body 75SeHCAT retention. Eur. J. Nucl. Med. Mol. Imaging 40, 1618\u20131621 (2013).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"BFnrgastro201432_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/gut.35.1.90","volume":"35","author":"H Nyhlin","year":"1994","unstructured":"Nyhlin, H., Merrick, M. V. & Eastwood, M. A. Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT. Gut 35, 90\u201393 (1994).","journal-title":"Gut"},{"key":"BFnrgastro201432_CR29","first-page":"448","volume":"34","author":"MJ Smith","year":"2000","unstructured":"Smith, M. J. et al. Bile acid malabsorption in persistent diarrhoea. J. R. Coll. Physicians Lond. 34, 448\u2013451 (2000).","journal-title":"J. R. Coll. Physicians Lond."},{"key":"BFnrgastro201432_CR30","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1365-2036.2009.04081.x","volume":"30","author":"L Wedlake","year":"2009","unstructured":"Wedlake, L., A'Hern, R., Thomas, K., Walters, J. R. F. & Andreyev, H. J. N. Systematic review: the prevalence of idiopathic bile acid malabsorption (I-BAM) as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome (IBS). Aliment. Pharmacol. Ther. 30, 707\u2013717 (2009).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201432_CR31","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1016\/j.ejim.2011.08.013","volume":"22","author":"MK Borghede","year":"2011","unstructured":"Borghede, M. K. et al. Bile acid malabsorption investigated by selenium-75-homocholic acid taurine (75SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea. Eur. J. Intern. Med. 22, e137\u2013e140 (2011).","journal-title":"Eur. J. Intern. Med."},{"key":"BFnrgastro201432_CR32","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3109\/00365521.2011.574728","volume":"46","author":"M Kurien","year":"2011","unstructured":"Kurien, M. et al. Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms. Scand. J. Gastroenterol. 46, 818\u2013822 (2011).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro201432_CR33","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/apt.12466","volume":"38","author":"SS Pattni","year":"2013","unstructured":"Pattni, S. S. et al. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention. Aliment. Pharmacol. Ther. 38, 967\u2013976 (2013).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201432_CR34","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/MNM.0b013e32835e8989","volume":"34","author":"MJ Smith","year":"2013","unstructured":"Smith, M. J. & Perkins, A. C. A survey of the clinical use of SeHCAT in the UK. Nucl. Med. Commun. 34, 306\u2013313 (2013).","journal-title":"Nucl. Med. Commun."},{"key":"BFnrgastro201432_CR35","unstructured":"NICE. National Institute for Health and Care Excellence [online]. SeHCAT (Tauroselcholic [75Selenium] acid) for the investigation of bile acid malabsorption (BAM) and measurement of bile acid pool loss. http:\/\/guidance.nice.org.uk\/DT\/8 (2013)."},{"key":"BFnrgastro201432_CR36","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3109\/00365529309103126","volume":"28","author":"S Eusufzai","year":"1993","unstructured":"Eusufzai, S. Bile acid malabsorption in patients with chronic diarrhoea. Scand. J. Gastroenterol. 28, 865\u2013868 (1993).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro201432_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00042737-199602000-00005","volume":"8","author":"WG Brydon","year":"1996","unstructured":"Brydon, W. G., Nyhlin, H., Eastwood, M. A. & Merrick, M. V. Serum 7 \u03b1-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur. J. Gastroenterol. Hepatol. 8, 117\u2013123 (1996).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201432_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1023\/A:1026681512303","volume":"44","author":"GH Sauter","year":"1999","unstructured":"Sauter, G. H., Munzing, W., von, R. C. & Paumgartner, G. Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7\u03b1-hydroxy-4-cholesten-3-one in serum. Dig. Dis. Sci. 44, 14\u201319 (1999).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro201432_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1155\/2011\/701287","volume":"25","author":"WG Brydon","year":"2011","unstructured":"Brydon, W. G. et al. An evaluation of the use of serum 7-\u03b1-hydroxycholestenone as a diagnostic test of bile acid malabsorption causing watery diarrhea. Can. J. Gastroenterol. 25, 319\u2013323 (2011).","journal-title":"Can. J. Gastroenterol."},{"key":"BFnrgastro201432_CR40","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1365-2796.2006.01731.x","volume":"260","author":"T Lundasen","year":"2006","unstructured":"Lundasen, T., Galman, C., Angelin, B. & Rudling, M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J. Intern. Med. 260, 530\u2013536 (2006).","journal-title":"J. Intern. Med."},{"key":"BFnrgastro201432_CR41","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1365-2796.2011.02466.x","volume":"270","author":"C Galman","year":"2011","unstructured":"Galman, C., Angelin, B. & Rudling, M. Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19. J. Intern. Med. 270, 580\u2013588 (2011).","journal-title":"J. Intern. Med."},{"key":"BFnrgastro201432_CR42","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1365-2982.2009.01288.x","volume":"21","author":"M Camilleri","year":"2009","unstructured":"Camilleri, M. et al. Measurement of serum 7\u03b1-hydroxy-4-cholesten-3-one (or 7\u03b1C4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol. Motil. 21, 734\u2013e43 (2009).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro201432_CR43","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.cgh.2012.05.006","volume":"10","author":"BS Wong","year":"2012","unstructured":"Wong, B. S. et al. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin. Gastroenterol. Hepatol. 10, 1009\u20131015 (2012).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201432_CR44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0022-2143(03)00040-4","volume":"141","author":"JL Porter","year":"2003","unstructured":"Porter, J. L. et al. Accurate enzymatic measurement of fecal bile acids in patients with malabsorption. J. Lab. Clin. Med. 141, 411\u2013418 (2003).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnrgastro201432_CR45","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1365-2982.2012.01893.x","volume":"24","author":"H Duboc","year":"2012","unstructured":"Duboc, H. et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol. Motil. 24, 513\u2013517 (2012).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro201432_CR46","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.cgh.2013.04.020","volume":"11","author":"A Shin","year":"2013","unstructured":"Shin, A. et al. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 11, 1270\u20131275 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201432_CR47","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1172\/JCI106644","volume":"50","author":"HS Mekjian","year":"1971","unstructured":"Mekjian, H. S., Phillips, S. F. & Hofmann, A. F. Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. J. Clin. Invest. 50, 1569\u20131577 (1971).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201432_CR48","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1172\/JCI107320","volume":"52","author":"HJ Binder","year":"1973","unstructured":"Binder, H. J. & Rawlins, C. L. Effect of conjugated dihydroxy bile salts on electrolyte transport in rat colon. J. Clin. Invest. 52, 1460\u20131466 (1973).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201432_CR49","doi-asserted-by":"publisher","first-page":"G290","DOI":"10.1152\/ajpgi.00076.2006","volume":"292","author":"SJ Keely","year":"2007","unstructured":"Keely, S. J. et al. Bile acid-induced secretion in polarized monolayers of T84 colonic epithelial cells: Structure\u2013activity relationships. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G290\u2013G297 (2007).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro201432_CR50","doi-asserted-by":"publisher","first-page":"11899","DOI":"10.3390\/s130911899","volume":"13","author":"JA Covington","year":"2013","unstructured":"Covington, J. A. et al. Application of a novel tool for diagnosing bile acid diarrhoea. Sensors (Basel) 13, 11899\u201311912 (2013).","journal-title":"Sensors (Basel)"},{"key":"BFnrgastro201432_CR51","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","volume":"284","author":"M Makishima","year":"1999","unstructured":"Makishima, M. et al. Identification of a nuclear receptor for bile acids. Science 284, 1362\u20131365 (1999).","journal-title":"Science"},{"key":"BFnrgastro201432_CR52","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","volume":"284","author":"DJ Parks","year":"1999","unstructured":"Parks, D. J. et al. Bile acids: natural ligands for an orphan receptor. Science 284, 1365\u20131368 (1999).","journal-title":"Science"},{"key":"BFnrgastro201432_CR53","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","volume":"3","author":"H Wang","year":"1999","unstructured":"Wang, H., Chen, J., Hollister, K., Sowers, L. C. & Forman, B. M. Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR. Mol. Cell 3, 543\u2013553 (1999).","journal-title":"Mol. Cell"},{"key":"BFnrgastro201432_CR54","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-1-4614-0887-1_11","volume":"728","author":"SA Jones","year":"2012","unstructured":"Jones, S. A. Physiology of FGF15\/19. Adv. Exp. Med. Biol. 728, 171\u2013182 (2012).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnrgastro201432_CR55","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1172\/JCI119355","volume":"99","author":"P Oelkers","year":"1997","unstructured":"Oelkers, P., Kirby, L. C., Heubi, J. E. & Dawson, P. A. Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). J. Clin. Invest. 99, 1880\u20131887 (1997).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201432_CR56","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/003655201750422693","volume":"36","author":"M Montagnani","year":"2001","unstructured":"Montagnani, M., Love, M. W., R\u00f6ssel, P., Dawson, P. A. & Qvist, P. Absence of dysfunctional ileal sodium-bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption. Scand. J. Gastroenterol. 36, 1077\u20131080 (2001).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro201432_CR57","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1038\/ctg.2012.10","volume":"3","author":"SS Pattni","year":"2012","unstructured":"Pattni, S. S., Brydon, W. G., Dew, T. & Walters, J. R. F. Fibroblast growth factor 19 and 7\u03b1-hydroxy-4-cholesten-3-one in the diagnosis of patients with possible bile acid diarrhea. Clin. Trans. Gastroenterol. 3, e18 (2012).","journal-title":"Clin. Trans. Gastroenterol."},{"key":"BFnrgastro201432_CR58","doi-asserted-by":"publisher","first-page":"15482","DOI":"10.1074\/jbc.275.20.15482","volume":"275","author":"C Yu","year":"2000","unstructured":"Yu, C. et al. Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J. Biol. Chem. 275, 15482\u201315489 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201432_CR59","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1172\/JCI23076","volume":"115","author":"S Ito","year":"2005","unstructured":"Ito, S. et al. Impaired negative feedback suppression of bile acid synthesis in mice lacking \u03b2Klotho. J. Clin. Invest. 115, 2202\u20132208 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201432_CR60","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1194\/jlr.M700351-JLR200","volume":"48","author":"D Jung","year":"2007","unstructured":"Jung, D. et al. FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption. J. Lipid Res. 48, 2693\u20132700 (2007).","journal-title":"J. Lipid Res."},{"key":"BFnrgastro201432_CR61","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/toxsci\/kfs011","volume":"126","author":"R Pai","year":"2012","unstructured":"Pai, R. et al. Antibody-mediated inhibition of fibroblast growth factor-19 results in increased bile acids synthesis and ileal malabsorption of bile acids in cynomolgus monkeys. Toxicol. Sci. 126, 446\u2013456 (2012).","journal-title":"Toxicol. Sci."},{"key":"BFnrgastro201432_CR62","doi-asserted-by":"publisher","first-page":"e66923","DOI":"10.1371\/journal.pone.0066923","volume":"8","author":"XX Yu","year":"2013","unstructured":"Yu, X. X. et al. Peripheral reduction of FGFR4 with antisense oligonucleotides increases metabolic rate and lowers adiposity in diet-induced obese mice. PLoS ONE 8, e66923 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201432_CR63","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1053\/j.gastro.2011.02.063","volume":"140","author":"BS Wong","year":"2011","unstructured":"Wong, B. S. et al. A Klotho-\u03b2 variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology 140, 1934\u20131942 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201432_CR64","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1053\/j.gastro.2010.07.052","volume":"139","author":"AS Rao","year":"2010","unstructured":"Rao, A. S. et al. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology 139, 1549\u20131558 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201432_CR65","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1007\/s10620-012-2035-5","volume":"57","author":"BS Wong","year":"2012","unstructured":"Wong, B. S. et al. Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea. Dig. Dis. Sci. 57, 1222\u20131226 (2012).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro201432_CR66","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/gut.2010.212159","volume":"60","author":"RM Gadaleta","year":"2011","unstructured":"Gadaleta, R. M. et al. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut 60, 463\u2013472 (2011).","journal-title":"Gut"},{"key":"BFnrgastro201432_CR67","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/ibd.21502","volume":"17","author":"M Lenicek","year":"2010","unstructured":"Lenicek, M. et al. Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers. Inflamm. Bowel. Dis. 17, 1322\u20131327 (2010).","journal-title":"Inflamm. Bowel. Dis."},{"key":"BFnrgastro201432_CR68","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1586\/egh.12.66","volume":"7","author":"JD Nolan","year":"2013","unstructured":"Nolan, J. D., Johnston, I. M. & Walters, J. R. Altered enterohepatic circulation of bile acids in Crohn's disease and their clinical significance: a new perspective. Expert Rev. Gastroenterol. Hepatol. 7, 49\u201356 (2013).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro201432_CR69","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.cmet.2013.04.007","volume":"17","author":"L Vergnes","year":"2013","unstructured":"Vergnes, L., Lee, J. M., Chin, R. G., Auwerx, J. & Reue, K. Diet1 functions in the FGF15\/19 enterohepatic signaling axis to modulate bile acid and lipid levels. Cell Metab. 17, 916\u2013928 (2013).","journal-title":"Cell Metab."},{"key":"BFnrgastro201432_CR70","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1126\/science.1198363","volume":"331","author":"S Kir","year":"2011","unstructured":"Kir, S. et al. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 331, 1621\u20131624 (2011).","journal-title":"Science"},{"key":"BFnrgastro201432_CR71","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/00365510701854967","volume":"68","author":"D Stejskal","year":"2008","unstructured":"Stejskal, D., Karpisek, M., Hanulova, Z. & Stejskal, P. Fibroblast growth factor-19: development, analytical characterization and clinical evaluation of a new ELISA test. Scand. J. Clin. Lab. Invest. 68, 501\u2013507 (2008).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"BFnrgastro201432_CR72","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1210\/en.2011-2145","volume":"153","author":"DJ Pournaras","year":"2012","unstructured":"Pournaras, D. J. et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 153, 3613\u20133619 (2012).","journal-title":"Endocrinology"},{"key":"BFnrgastro201432_CR73","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1572-0241.2004.04139.x","volume":"99","author":"R Sadik","year":"2004","unstructured":"Sadik, R., Abrahamsson, H., Ung, K.-A. & Stotzer, P.-O. Accelerated regional bowel transit and overweight shown in idiopathic bile acid malabsorption. Am. J. Gastroenterol. 99, 711\u2013718 (2004).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201432_CR74","doi-asserted-by":"publisher","first-page":"16137","DOI":"10.1073\/pnas.1205951109","volume":"109","author":"T Fu","year":"2012","unstructured":"Fu, T. et al. Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor \u03b2-Klotho. Proc. Natl Acad. Sci. USA 109, 16137\u201316142 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201432_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jsbmb.2012.04.008","volume":"132","author":"M Miyata","year":"2012","unstructured":"Miyata, M. et al. Involvement of multiple elements in FXR-mediated transcriptional activation of FGF19. J. Steroid Biochem. Mol. Biol. 132, 41\u201347 (2012).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"BFnrgastro201432_CR76","doi-asserted-by":"publisher","first-page":"14486","DOI":"10.1074\/jbc.M110.116004","volume":"285","author":"DR Schmidt","year":"2010","unstructured":"Schmidt, D. R. et al. Regulation of bile acid synthesis by fat-soluble vitamins A and D. J. Biol. Chem. 285, 14486\u201314494 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201432_CR77","doi-asserted-by":"publisher","first-page":"G940","DOI":"10.1152\/ajpgi.00398.2012","volume":"304","author":"JH Zhang","year":"2013","unstructured":"Zhang, J. H. et al. Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G940\u2013G948 (2013).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro201432_CR78","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1021\/jm025529g","volume":"45","author":"R Pellicciari","year":"2002","unstructured":"Pellicciari, R. et al. 6\u03b1-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. J. Med. Chem. 45, 3569\u20133572 (2002).","journal-title":"J. Med. Chem."},{"key":"BFnrgastro201432_CR79","doi-asserted-by":"publisher","unstructured":"Mroz, M. S. et al. Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo. Gut http:\/\/dx.doi.org\/10.1136\/gutjnl-2013-305088 .","DOI":"10.1136\/gutjnl-2013-305088"},{"key":"BFnrgastro201432_CR80","doi-asserted-by":"publisher","first-page":"9435","DOI":"10.1074\/jbc.M209706200","volume":"278","author":"Y Kawamata","year":"2003","unstructured":"Kawamata, Y. et al. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 278, 9435\u20139440 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201432_CR81","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","volume":"298","author":"T Maruyama","year":"2002","unstructured":"Maruyama, T. et al. Identification of membrane-type receptor for bile acids (M-BAR). Biochem. Biophys. Res. Commun. 298, 714\u2013719 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrgastro201432_CR82","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.gastro.2012.09.055","volume":"144","author":"F Alemi","year":"2013","unstructured":"Alemi, F. et al. The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. Gastroenterology 144, 145\u2013154 (2013).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201432_CR83","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.1021\/jm901390p","volume":"52","author":"R Pellicciari","year":"2009","unstructured":"Pellicciari, R. et al. Discovery of 6\u03b1-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity. J. Med. Chem. 52, 7958\u20137961 (2009).","journal-title":"J. Med. Chem."},{"key":"BFnrgastro201432_CR84","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/nmo.12148","volume":"25","author":"JB Ward","year":"2013","unstructured":"Ward, J. B., Mroz, M. S. & Keely, S. J. The bile acid receptor, TGR5, regulates basal and cholinergic-induced secretory responses in rat colon. Neurogastroenterol. Motil. 25, 708\u2013711 (2013).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro201432_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1248\/bpb.34.1","volume":"34","author":"Y Iguchi","year":"2011","unstructured":"Iguchi, Y. et al. Effects of chemical modification of ursodeoxycholic acid on TGR5 activation. Biol. Pharm. Bull. 34, 1\u20137 (2011).","journal-title":"Biol. Pharm. Bull."},{"key":"BFnrgastro201432_CR86","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/j.1365-2982.2011.01772.x","volume":"23","author":"M Camilleri","year":"2011","unstructured":"Camilleri, M. et al. Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders. Neurogastroenterol. Motil. 23, 995\u2013999 (2011).","journal-title":"Neurogastroenterol. Motil."},{"key":"BFnrgastro201432_CR87","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-\u03b2-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225\u2013235 (2013).","journal-title":"Cell Metab."},{"key":"BFnrgastro201432_CR88","unstructured":"US National Library of Medicine. ClinicalTrials.gov [online] , (2013)."},{"key":"BFnrgastro201432_CR89","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1053\/j.gastro.2013.05.042","volume":"145","author":"S Mudaliar","year":"2013","unstructured":"Mudaliar, S. et al. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. Gastroenterology 145, 574\u2013582 (2013).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201432_CR90","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/S0016-5085(13)60217-6","volume":"144","author":"IM Johnston","year":"2013","unstructured":"Johnston, I. M., Nolan, J. D., Dew, T., Shapiro, D. & Walters, J. R. F. A new therapy for chronic diarrhea? A proof of concept study of the FXR agonist obeticholic acid in patients with primary bile acid diarrhea. Gastroenterology 144, S60 (2013).","journal-title":"Gastroenterology"}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2014.32","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2014.32.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2014.32.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:51:21Z","timestamp":1684468281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2014.32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,25]]},"references-count":90,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["BFnrgastro201432"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2014.32","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,25]]}}}